2023Q1营收暴增65.6%,营业利润和净利润均扭亏,从季报环比看,近5个月营收和利润的季报环比持续增长,是个扭...查看全文
阿浦美股2021-03-10 21:24
【财报资讯:阿尼制药ANIP】
$阿尼制药(ANIP)$ 于3月9日公布了2020财年第四季度及2020财年全年财报。
根据财报数据显示,该公司2020财年第四季度营业收入达5730万美元,与上年同期4800万美元相比增长19%;净利润亏损360万美元;调整后每股收益为0.8美元。2020全年营业收入为2.085亿美元,...查看全文
疯投哥2015-07-02 13:55
1、截止2015年6月30日,我赚钱最多的组合是$疯投A股(ZH053729)$,收益率是47.92%;
赚钱最少的组合是$空就是多(ZH011311)$,收益率是-49.86%;
2、最近三个月,我的组合调仓次数43,赚钱次数是18;
3、截止2015年6月30日,我的组合前5大持仓股票分别是$达内科技(TEDU)$,$MALLINCKRODT PUB...查看全文
$ANI PHARMACEUTICALS INC(ANIP)$ 美东时间 2017-03-02 盘前 披露财报,预期EPS 1.02 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ 8-K - Current report Filed: 2017-02-16 AccNo: 0001144204-17-009465 Size: 102 KBItem 2.02: Results of Operations and Financial ConditionItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial State...
$ANI PHARMACEUTICALS INC(ANIP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0001628280-17-001304 Size: 97 KB 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-13 AccNo: 0001085146-17-000621 Size: 57 KB 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-19 AccNo: 0000215457-17-001265 Size: 13 KB 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-01-19 AccNo: 0000215457-17-001265 Size: 13 KB 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ 8-K - Current report Filed: 2016-11-14 AccNo: 0001144204-16-133655 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-11-03 AccNo: 0001144204-16-131408 Size: 80 KB 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-03 AccNo: 0001144204-16-131405 Size: 4 MB 网页链接
$ANI PHARMACEUTICALS INC(ANIP)$ 8-K - Current report Filed: 2016-11-03 AccNo: 0001144204-16-131250 Size: 338 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接